Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies.

An additional limitation relates to the relatively small sample size of the thermochemotherapy group, which may have reduced statistical power and contributed to the borderline significance observed in multivariable analyses.

also in 7,017 other papers

In the thermochemotherapy group, PLR > 120 demonstrated a strong but borderline association with recurrence-free survival (HR = 23.265, 95% CI: 0.952–568.336, p = 0.054); however, this association did not reach statistical significance after adjustment for age, tumor size, and tumor number.

also in 111,027 other papers